NCT02538627 2017-09-05Phase 1 Combination Study of MM-151 With MM-121, MM-141, or TrametinibMerrimack PharmaceuticalsPhase 1 Terminated5 enrolled
NCT01447225 2016-09-14Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid TumorsMerrimack PharmaceuticalsPhase 1 Completed43 enrolled 21 charts
NCT00734305 2016-09-01Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary TreatmentMerrimack PharmaceuticalsPhase 1 Completed44 enrolled 12 charts